Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
71.50
+1.71 (2.45%)
Nov 4, 2025, 4:00 PM EST - Market closed
Tarsus Pharmaceuticals Market Cap
Tarsus Pharmaceuticals has a market cap or net worth of $3.02 billion as of November 5, 2025. Its market cap has increased by 114.03% in one year.
Market Cap
3.02B
Enterprise Value
2.69B
1-Year Change
114.03%
Ranking
Category
Stock Price
$71.50
Market Cap Chart
Since the IPO on October 16, 2020, Tarsus Pharmaceuticals's market cap has increased from $308.14M to $3.02B, an increase of 879.51%. That is a compound annual growth rate of 57.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 2.95B | 39.19% |
| Dec 31, 2024 | 2.12B | 215.74% |
| Dec 29, 2023 | 670.37M | 71.44% |
| Dec 30, 2022 | 391.01M | -15.95% |
| Dec 31, 2021 | 465.23M | -44.60% |
| Dec 31, 2020 | 839.84M | 172.55% |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 812.64B |
| Johnson & Johnson | 450.10B |
| AbbVie | 381.36B |
| UnitedHealth Group | 299.67B |
| AstraZeneca | 253.45B |
| Novartis AG | 240.68B |
| Abbott Laboratories | 218.65B |
| Novo Nordisk | 215.64B |